Sulfacetamide Sodium NDC 24208-670

NDC codes

FDA NDC Directory

Product NDC (as listed)24208-670Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24208-0670Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24208-670-04	24208067004	1 BOTTLE, DROPPER in 1 CARTON (24208-670-04) / 15 mL in 1 BOTTLE, DROPPERMarketed from Dec 28, 1994

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sulfacetamide Sodium
Generic name (nonproprietary): sulfacetamide sodium
Active ingredients: Sulfacetamide sodium — 100 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Bausch & Lomb Incorporated
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040066
Marketing start: Dec 28, 1994
Listing expires: Dec 31, 2026
Other FDA classes: Sulfonamides (Chemical structure)
Identifiers: Product ID 24208-670_39869c1b-2b30-482e-b88e-9177cd85ea16SPL ID 39869c1b-2b30-482e-b88e-9177cd85ea16SPL set ID 6c1b2658-e756-4f31-9bc8-f99a0baa4637RxCUI 1006120UNII 4NRT660KJQ
Pharmacologic class: Sulfonamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424208067004 followed by a unit qualifier and the quantity

Package 24208-0670-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 31, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Sulfacetamide sodium ophthalmic solution USP, 10% is indicated for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunctive in systemic sulfonamide therapy of trachoma: Escherichia coli, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus (viridans group), Haemophilus influenzae, Klebsiella species, and Enterobacter species. Topically applied sulfonamides do not provide adequate coverage against Neisseria species, Serratia marcescens and Pseudomonas aeruginosa . A significant percentage of staphylococcal isolates are completely resistant to sulfa drugs.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040066

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040066
Product	Strength	Form · route	Labeler	Product NDC
Sulfacetamide Sodium	Sulfacetamide sodium 100 mg/mL	Solution/ dropsOphthalmic	A-S Medication Solutions	50090-0246
Sulfacetamide Sodium	Sulfacetamide sodium 100 mg/mL	Solution/ dropsOphthalmic	NuCare Pharmaceuticals,Inc.	68071-5123
Sulfacetamide Sodium	Sulfacetamide sodium 100 mg/mL	Solution/ dropsOphthalmic	Proficient Rx LP	71205-689
Sulfacetamide Sodium	Sulfacetamide sodium 100 mg/mL	Solution/ dropsOphthalmic	Asclemed USA, Inc.	76420-090
Sulfacetamide Sodium	Sulfacetamide sodium 100 mg/mL	Solution/ dropsOphthalmic	Preferred Pharmaceuticals, Inc	68788-9871